3D printed implants for long-acting drug delivery

Aikaterini Dedeloudi, Sune Andersen, Peyton Hopson, Dimitrios A. Lamprou*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Abstract

3D-printed implantable drug delivery systems (DDSs) are a class of novel therapeutic approaches with promising characteristics for developing personalised therapies. The pharmacokinetic and pharmacodynamic profile of long-acting implantable drug release scaffolds provide significant potential in reducing treatment limitations, like patient compliance, therapeutic threshold, drug bioavailability, and side effects. The manufacturing process of 3D-printed implants involves an initial selection of materials, techniques, and a rational formulation process design. Physico-chemical characteristics of materials, material compatibility, and manufacturing techniques are critical in developing diverse and multifunctional scaffolds defined by a long-acting drug release rate. In this chapter, an overview in manufacturing techniques, DDSs classification, critical design parameters, and prospects of 3D-printed implantable DDSs is given.

Original languageEnglish
Title of host publication3D printing of pharmaceutical and drug delivery devices: progress from bench to bedside
EditorsDimitrios A. Lamprou, Dennis Douroumis, Sheng Qi
PublisherJohn Wiley & Sons Ltd
Chapter5
Pages89-114
ISBN (Electronic)9781119836001
ISBN (Print)9781119835974
DOIs
Publication statusPublished - 13 May 2024

Publication series

NameAdvances in Pharmaceutical Technology

Keywords

  • 3D Printing
  • Implantable Scaffolds
  • Implant
  • Drug Delivery Systems
  • Additive Manufacturing
  • Biomaterials

Fingerprint

Dive into the research topics of '3D printed implants for long-acting drug delivery'. Together they form a unique fingerprint.

Cite this